Moehs Group, a reference company in the production of pharmaceutical active ingredients.
01 1Moehs Iberica SL
02 1APICHEM Laboratories Private Limited
03 1Aurobindo Pharma Limited
04 1Catalent Micron Technologies, Inc.
05 1Dasami Lab Private Limited
06 1Maithri Drugs Private Limited
07 1PPL Pharma Solutions Riverview LLC
08 1SK biotek Ireland Limited
01 8Mavacamten
01 1China
02 2India
03 1Spain
04 2U.S.A
05 2Blank
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 81912-0003
Start Marketing Date : 2025-10-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84386-138
Start Marketing Date : 2025-10-10
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69988-0060
Start Marketing Date : 2022-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 81666-008
Start Marketing Date : 2025-03-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-050
Start Marketing Date : 2024-03-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50193-4423
Start Marketing Date : 2024-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48957-0091
Start Marketing Date : 2022-04-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 70966-0045
Start Marketing Date : 2025-10-13
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
61
PharmaCompass offers a list of Mavacamten API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mavacamten manufacturer or Mavacamten supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mavacamten manufacturer or Mavacamten supplier.
PharmaCompass also assists you with knowing the Mavacamten API Price utilized in the formulation of products. Mavacamten API Price is not always fixed or binding as the Mavacamten Price is obtained through a variety of data sources. The Mavacamten Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mavacamten manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mavacamten, including repackagers and relabelers. The FDA regulates Mavacamten manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mavacamten API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mavacamten manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mavacamten supplier is an individual or a company that provides Mavacamten active pharmaceutical ingredient (API) or Mavacamten finished formulations upon request. The Mavacamten suppliers may include Mavacamten API manufacturers, exporters, distributors and traders.
click here to find a list of Mavacamten suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mavacamten as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mavacamten API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mavacamten as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mavacamten and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mavacamten NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mavacamten suppliers with NDC on PharmaCompass.
We have 6 companies offering Mavacamten
Get in contact with the supplier of your choice:
